|Articles|June 22, 2009
FDA's Keith Webber on Setting Specifications
Author(s)BioPharm International Editors
Advertisement
FDA´s Keith Webber on Setting Specifications
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5